IP Library Granted Patent US 10,385,074
Granted Patent B2
US 10,385,074 · App. 15/305,954 · Granted Aug 20, 2019

Synthesis of boronate salts and uses thereof

Inventors: Scott Hecker (Del Mar, CA); Serge Boyer (San Diego, CA)
Assignee: REMPEX PHARMACEUTICALS, INC.
C07F5/025A01N55/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,385,074
App. No.
15/305,954
Granted
Aug 20, 2019
Kind
B2
Abstract

Disclosed herein are boronate intermediates in the synthesis of antimicrobial compounds and the use and preparation thereof. Some embodiments relate to crystalline boronate salt derivatives and their use in the synthesis of therapeutic compounds.

Claims (66)

1. A compound of Formula (I)

or a salt thereof, wherein:

n is 0 or 1;

Y 1 is O or N + R 5 R 6 ;

Y 2 is O or NR 10 ;

R 1 and R 2 are independently selected from the group consisting of H, optionally substituted phenyl and optionally substituted C 1 - 4 alkyl, or R 1 and R 2 together with the atoms to which they are attached, form ═O;

R 3 is selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl, or R 3 and R 5 , together with the atoms to which they are attached, form a heteroaryl ring; or R 3 and R 4 together with the atoms to which they are attached, form ═O;

R 4 , R 5 , R 6 , and R 10 are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl; and

R 9 is selected from the group consisting of optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, and optionally substituted heteroaryl.

2. The compound of claim 1 , wherein Y 1 is O.

3. The compound of claim 1 , wherein Y 1 is N + R 5 R 6 .

4. The compound of claim 1 , wherein Y 2 is O.

5. The compound of claim 1 , wherein R 1 and R 2 are both H.

6. The compound of claim 1 , wherein R 1 and R 2 together with the atoms to which they are attached, form ═O and wherein R 3 and R 4 together with the atoms to which they are attached, form ═O.

7. The compound of claim 1 , wherein R 3 and R 4 are both H.

8. The compound of claim 1 , wherein R 5 and R 6 are both H.

9. The compound of claim 1 , wherein R 9 is optionally substituted C 1 -C 12 alkyl.

10. The compound of claim 1 , having a structure selected from the group consisting of:

wherein:

M + is a cation selected from the group consisting of lithium, sodium, potassium, calcium, ammonium, triethylammonium, and aluminum.

11. A method of making a compound of Formula (I), or a salt thereof, comprising the steps of:

(a) protecting the hydroxy group of a compound of Formula (A):

to form a compound of Formula (B):

(b) reacting a compound of Formula (B) with a compound of Formula (C):

to form a compound of Formula (D):

(c) deprotecting a compound of Formula (D) to form a compound of Formula (E):

(d) reacting a compound of Formula (E) with a complexing agent of Formula (F):

to form a compound of Formula (I):

wherein:

PG is a hydroxyl protecting group;

n is 0 or 1;

Y 1 is O or N + R 5 R 6

Y 2 is O or NR 10 ;

R 1 and R 2 are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1 - 4 alkyl, or R 1 and R 2 together with the atoms to which they are attached, form ═O;

R 3 is selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl, or R 1 and R 3 together with the atoms to which they are attached form an aryl or heteroaryl ring; or R 3 and R 4 together with the atoms to which they are attached, form ═O;

R 4 , R 5 , R 6 , and R 10 are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl;

R 9 is optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl, or optionally substituted heteroaryl;

R 11 is selected from the group consisting of substituted or unsubstituted variants of the following: C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 3 -C 12 heterocyclyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and (cycloalkyl)alkyl, and

X is selected from the group consisting of substituted or unsubstituted variants of the following: C 1 -C 4 alkyl, C 2 -C 4 alkenyl, and C 2 -C 4 alkynyl; and

R 12 is selected from the group consisting of substituted or unsubstituted variants of the following: C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 3 -C 12 heterocyclyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and (cycloalkyl)alkyl.

12. The method of claim 11 , wherein R 1 and R 2 are both H.

13. The method of claim 11 , wherein R 1 and R 2 together with the atoms to which they are attached, form ═O and wherein R 3 and R 4 together with the atoms to which they are attached, form ═O.

14. The method of claim 11 , wherein R 3 and R 4 are both H.

15. The method of claim 11 , wherein R 5 and R 6 are both H.

16. The method of claim 11 , wherein R 9 is optionally substituted C 1 -C 12 alkyl.

17. A method of making a compound of Formula (I), or a salt thereof,

comprising the steps of:

reacting a compound of Formula (E):

with a complexing agent of Formula (F):

to form a compound of Formula (I):

wherein

n is 0 or 1,

Y 1 is O or N + R 5 R 6

Y 2 ═O or NR 10 ,

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 10 are independently selected from the group consisting of H, optionally substituted phenyl, and optionally substituted C 1-4 alkyl; or

wherein independently two geminal R 1 , R 2 , R 3 , R 4 together with the atoms to which they are attached, form ═O; and

wherein R 9 is optionally substituted C 1 -C 12 alkyl, optionally substituted C 3 -C 8 cycloalkyl, optionally substituted C 2 -C 12 alkenyl, optionally substituted C 2 -C 12 alkynyl, optionally substituted aryl or, optionally substituted heteroaryl.

18. The method of claim 17 , wherein n is 1.

19. The method of claim 17 , wherein Y 1 is N + R 5 R 6 .

20. The method of claim 17 , wherein Y 2 is NR 10 .

21. The method of claim 17 , wherein R 1 and R 2 are both H.

22. The method of claim 17 , wherein R 3 and R 4 are both H.

23. The method of claim 17 , wherein R 1 and R 2 together with the atoms to which they are attached, form ═O and wherein R 3 and R 4 together with the atoms to which they are attached, form ═O.

24. The method of claim 17 , wherein R 5 and R 6 are both H.

25. The method of claim 17 , wherein R 9 is optionally substituted C 1 -C 12 alkyl.

26. The method of claim 17 , wherein R 9 is t-butyl.

Assignments (7)
AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 25, 2022
From: MELINTA SUBSIDIARY CORP.
To: SILICON VALLEY BANK
Reel/Frame 061314/0572 →
CHANGE OF NAME Recorded Dec 30, 2020
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 054778/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2020
From: REMPEX PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 054755/0846 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 22, 2020
From: REMPEX PHARMACEUTICALS, INC.
To: SILICON VALLEY BANK
Reel/Frame 054836/0739 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS AND ASSIGNOR'S EXECUTION DATE PREVIOUSLY RECORDED AT REEL: 040149 FRAME: 0157. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jun 13, 2019
From: HECKER, SCOTT; BOYER, SERGE
To: REMPEX PHARMACEUTICALS, INC.
Reel/Frame 049457/0503 →
SECURITY INTEREST Recorded Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2016
From: HECKER, SCOTT; BOYER, SERGE
To: REMPEX PHARMACEUTICALS, INC.
Reel/Frame 040149/0157 →
Continuity (2)
Provisional Application 61988690 · May 5, 2014
Related Publication 20170057979A1 · Mar 2, 2017